News in English
Enter any phrase or word you would like to search for and click .
PostNews: Interim Report
Interim Report 2 2022/23
The online sales and lead generation strategy continues to deliver. As a result, sales from August to October this year reached 2.7 KSEK — an increase of 50 % compared to any previous corresponding period.
Learn more …
PostNews
BioStock: PHI on the alliance for cell-based biomanufacturing
Kersti Alm, CSO at PHI, visited BioStock’s studio to talk about the recently created alliance for advancing cell-based biomanufacturing and PHI’s pivotal role in the collaboration.
Learn more …
PostNews: Press Release
PHI Is Opening A New Development Office In The US
As a result of the newly created alliance for advancing cell-based biomanufacturing which was recently communicated, PHI is taking the next step in its investment into regenerative medicine by opening an office in the Innovation Quarter in Winston-Salem.
Learn more …
PostNews
BioStock: PHI part of new regenerative medicine alliance
BioStock contacted Product Manager Lisa Lindström to learn more about PHI’s newly formed technology development alliance for regenerative medicine and what excites her about the future.
Learn more …
PostNews: Press Release
PHI, SAS, QIAGEN and BioSpherix form Alliance to Advance Cell-based Biomanufacturing
In association with the Wake Forest Institute for Regenerative Medicine, PHI, BioSpherix, analytics leader SAS and QIAGEN have created a technology development alliance to create the AI-based process control tools needed for automated biomanufacturing.
Learn more …
PostNews
BioStock: PHI expands market potential with regenerative medicine opportunity
BioStock contacted CFO Patrik Eschricht to find out more about PHI’s visions regarding regenerative medicine, cell-based therapies and automatization of biomanufacturing.
Learn more …
